Hope for liver disease: new drug trial targets PBC symptoms
NCT ID NCT06427395
First seen Feb 21, 2026 · Last updated Jun 16, 2026 · Updated 15 times
Summary
This study tests a drug called saroglitazar magnesium in people with primary biliary cholangitis (PBC), a chronic liver disease. The goal is to see if the drug is safe and helps control the disease. About 102 adults who completed a previous PBC study will take the drug and be monitored for side effects and liver health improvements.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zydus AR001
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1118AAT, Argentina
-
Zydus AR003
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1430CKE, Argentina
-
Zydus AR004
Pilar, Buenos Aires, B1629ODT, Argentina
-
Zydus AR005
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1425BGC, Argentina
-
Zydus AR006
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1221ADC, Argentina
-
Zydus AR007
Ciudad Autónoma de Buenos Aires, Buenos Aires, C1199ABB, Argentina
-
Zydus TR004
Ankara, 06800, Turkey (Türkiye)
-
Zydus TR005
Bursa, 16059, Turkey (Türkiye)
-
Zydus TR015
Melikgazi, 38039, Turkey (Türkiye)
-
Zydus TR016
Altındağ, 06230, Turkey (Türkiye)
-
Zydus TR017
Cebeli, 06620, Turkey (Türkiye)
-
Zydus US001
Indianapolis, Indiana, 46202, United States
-
Zydus US002
Charlotte, North Carolina, 28204, United States
-
Zydus US005
Miami, Florida, 33136, United States
-
Zydus US006
Lakewood Rch, Florida, 34211, United States
-
Zydus US011
Pasadena, California, 91105, United States
-
Zydus US013
Los Angeles, California, 90048, United States
-
Zydus US016
Charlottesville, Virginia, 22908, United States
-
Zydus US020
Marietta, Georgia, 30060, United States
-
Zydus US022
Aurora, Colorado, 80045, United States
-
Zydus US027
Jacksonville, Florida, 32224, United States
-
Zydus US031
Murray, Utah, 84107, United States
-
Zydus US033
Seattle, Washington, 98105, United States
-
Zydus US035
Rochester, New York, 14642, United States
-
Zydus US037
New Haven, Connecticut, 06520, United States
-
Zydus US039
Richmond, Virginia, 23298, United States
-
Zydus US042
Houston, Texas, 77030, United States
-
Zydus US043
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.